- The U.S. Supreme Court Chief Justice John Roberts denies Teva's (NYSE:TEVA) application for an injunction to prevent Mylan (MYL) from launching a generic version of Copaxone until the Court rules on the matter later this year.
- The ruling opens the door for generic firms to launch their versions as early as next month.
Teva denied injunction
Recommended For You
More Trending News
About TEVA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TEVA | - | - |
Teva Pharmaceutical Industries Limited |